The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

FILANA THERAPEUTICS, INC. insider acquisitions

Company CIK 0001069530 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
FLNA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 22, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
PurchaseCode PCommon StockNon-derivative · Currency not specified2278,131.70

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Barry RichardBarry RichardAnderson Robert Eugene JrAnderson Robert Eugene JrBir Dawn CarterBir Dawn CarterBarry Richard · September 30, 2026 · Purchase · Common StockBarry Richard · September 29, 2026 · Purchase · Common StockAnderson Robert Eugene Jr · November 24, 2025 · Purchase · Common StockBarry Richard · November 20, 2025 · Purchase · Common StockBarry Richard · November 19, 2025 · Purchase · Common StockBir Dawn Carter · October 21, 2025 · Stock award · Stock Option (Right to Buy)Oct 21, 2025Sep 30, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Sep 30, 2026FILANA THERAPEUTICS, INC.Common StockBarry RichardPurchase
Sep 29, 2026FILANA THERAPEUTICS, INC.Common StockBarry RichardPurchase
Nov 24, 2025FILANA THERAPEUTICS, INC.Common StockAnderson Robert Eugene JrPurchase
Nov 20, 2025FILANA THERAPEUTICS, INC.Common StockBarry RichardPurchase
Nov 19, 2025FILANA THERAPEUTICS, INC.Common StockBarry RichardPurchase
Oct 21, 2025FILANA THERAPEUTICS, INC.Stock Option (Right to Buy)Bir Dawn CarterStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

FLNA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Barry RichardPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P100,0000.92 *Value: 92,000Currency not specifiedView ↗
Trade:
Barry RichardPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P206,8130.9 *Value: 186,131.7Currency not specifiedView ↗
Trade: PurchaseCommon StockNon-derivative security · Code P8,6002.9Value: 24,940Currency not specifiedView ↗
Trade:
Barry RichardPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P150,0002.76 *Value: 414,000Currency not specifiedView ↗
Trade:
Barry RichardPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P73,3852.75 *Value: 201,808.75Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A53,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →